Ten-day decitabine with venetoclax versus intensive chemotherapy in relapsed or refractory acute myeloid leukemia: A propensity score-matched analysis.
Abhishek MaitiCourtney D D DiNardoWei QiaoTapan Mahendra KadiaElias J JabbourCaitlin R RauschNaval G DaverNicholas James ShortGautam BorthakurNaveen PemmarajuMusa YilmazYesid AlvaradoKathryn S MontalbanoAllison WadeRita E MaduikeJulio A GuerreroKenneth VaughanCarol A BivinsSherry PierceJing NingFarhad RavandiHagop M KantarjianMarina Y KonoplevaPublished in: Cancer (2021)
DEC10-VEN represents an appropriate salvage therapy and may offer better responses and survival compared with IC in adults with R/R AML.